ENHANCING RECOVERY IN ATHLETES: ASSESSING THE EFFICACY OF PLATELET-RICH PLASMA THERAPY FOR ROTATOR CUFF INJURY REHABILITATION

Abstract

Objective: This study aims to evaluate the effectiveness of platelet-rich plasma (PRP) therapy in accelerating soft tissue healing in athletes with rotator cuff injuries. Methods: A controlled study was conducted from January 2022 to January 2023, involving 32 athletes diagnosed with rotator cuff injuries. Participants were randomly assigned into two groups, with 16 athletes in each. The control group received PRP injections, where 8ml of autologous platelet-rich plasma was administered under CT guidance into the subacromial space. The observation group received 8ml of autologous venous blood under similar conditions. Treatment outcomes were monitored, comparing the visual analogue scale (VAS), Constant-Murley score (CMS), and shoulder range of motion (ROM) both at six weeks and six months post-treatment, focusing on forward flexion, abduction, internal rotation, and external rotation. Results: Significant differences were noted in treatment outcomes between the control and observation groups (P < 0.05). The control group, treated with PRP, showed superior improvements in pain reduction (VAS), functional recovery (CMS), and enhanced shoulder ROM compared to the observation group. Conclusion: The administration of platelet-rich plasma directly into the subacromial space of athletes with rotator cuff injuries significantly enhances the healing process compared to treatment with autologous venous blood. PRP therapy proves to be a more effective method for promoting soft tissue recovery, thereby potentially shortening recovery times and improving functional outcomes in athletic populations within six months of treatment. This supports the broader application of PRP therapy in sports medicine for treating similar injuries.